Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma

NeuroReport

Volumn 26, Issue 2, 2015, Pages 66-73

  Ruan, Jian ^a,b   Lou, Silong ^b   Dai, Qinbi ^b   Mao, Deqiang ^b   Ji, Jia ^b   Sun, Xiaochuan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Cancer Institute   (China)

Author keywords

glioblastoma; glioblastoma multiforme; invasion; miR 181c; Notch2; proliferation; self renewal

Indexed keywords

MICRORNA; MICRORNA 181 C; NOTCH2 RECEPTOR; UNCLASSIFIED DRUG; MIRN181 MICRORNA, HUMAN; TUMOR MARKER;

ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; DILUTION; DOWN REGULATION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BRAIN TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR INVASION;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84920809878     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000302     Document Type: Article

References (25)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29.
2. Berindan-Neagoe I, Monroig PD, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin 2014; 64:311-336.
3. Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005; 334:1351-1358.
4. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008; 68:9125-9130.
5. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y. hsa-mir-181a and hsamir-181b function as tumor suppressors in human glioma cells. Brain Res 2008; 1236:185-193.
6. Cui MH, Hou XL, Lei XY, Mu FH, Yang GB, Yue L, et al. Upregulation of microRNA 181c expression in gastric cancer tissues and plasma. Asian Pac J Cancer Prev 2013; 14:3063-3066.
7. Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, et al. Expression of microRNAs in basal cell carcinoma. Br J Dermatol 2012; 167:847-855.
8. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72:1865-1877.
9. Li Y, Wang H, Li J, Yue W. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7. Acta Biochim Biophys Sin (Shanghai) 2014; 46:48-55.
10. Lakomy R, Sana J, Hankeova S, Fadrus P, Kren L, Lzicarova E, et al. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 2011; 102:2186-2190.
11. Liu S, Yin F, Zhang J,Wicha MS, Chang AE, FanW, et al. Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells. J Cell Biochem 2014; 115:1368-1380.
12. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford) 2010; 2010:baq020.
13. Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10:7252-7259.
14. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9:157-173.
15. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, et al. The somatic genomic landscape of glioblastoma. Cell 2013; 155:462-477.
16. Ozawa T, Riester M, Cheng YK, Huse JT, Squatrito M, Helmy K, et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneurallike precursor glioma. Cancer Cell 2014; 26:288-300.
17. Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, Schiemann WP. TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest 2013; 123:150-163.
18. Zhu W, Shan X, Wang T, Shu Y, Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010; 127:2520-2529.
19. Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 2010; 31:777-784.
20. Karsy M, Arslan E, Moy F. Current Progress on understanding microRNAs in glioblastoma multiforme. Genes Cancer 2012; 3:3-15.
21. Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 2013; 73:6046-6055.
22. Sanchez-Diaz PC, Hsiao TH, Chang JC, Yue D, Tan MC, Chen HI, et al. Deregulated microRNAs in pediatric cancer stem cells target pathways involved in cell proliferation, cell cycle and development. PloS One 2013; 8:e61622.
23. Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, et al. Therapeutic antibody targeting of individual Notch receptors. Nature 2010; 464:1052-1057.
24. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 2009; 279:13-21.
25. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010; 28:17-28.